Perceptive Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Perceptive Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-50,251	Closed	-$470K	–	219
2016 Q4	$470K	Sell	50,251 -375,797	-88%	-$3.38M	0.03%	121
2016 Q3	$4.17M	Sell	426,048 -232,803	-35%	-$3.14M	0.27%	74
2016 Q2	$9.31M	Buy	658,851 +8,260	+1%	+$129K	0.65%	39
2016 Q1	$9.1M	Sell	650,591 -210,922	-24%	-$3.09M	0.8%	32
2015 Q4	$17.6M	Buy	861,513 +10,521	+1%	+$162K	1.3%	20
2015 Q3	$5.59M	Buy	850,992 +550,070	+183%	+$9.12M	0.45%	50
2015 Q2	$4.62M	Sell	300,922 -300	-0.1%	-$5.75K	0.28%	70
2015 Q1	$6.02M	Hold	301,222	–	–	0.47%	45
2014 Q4	$6.33M	Buy	301,222 +4,244	+1%	+$86.4K	0.53%	46
2014 Q3	$5.53M	Buy	296,978 +150,000	+102%	+$2.72M	0.56%	42
2014 Q2	$3.4M	Buy	+146,978	New	+$2.59M	0.33%	52

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's AGTC Position: Q1 2017 in Review

Perceptive Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2017, closing a stake of 50,251 shares — an estimated $470K sold.

Perceptive Advisors first reported a position in AGTC in Q2 2014 and held it in 11 quarters. The position peaked at $17.6M in Q4 2015. 89 funds tracked by Wall St. Rank hold AGTC as of Q1 2017.

Perceptive Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q1 2017 after selling out during the quarter.
Perceptive Advisors sold 50,251 Applied Genetic Technologies Corporation shares in Q1 2017, an estimated $470K.
Perceptive Advisors first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 11 quarters.
Perceptive Advisors's Applied Genetic Technologies Corporation position peaked at $17.6M in Q4 2015.
89 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.